scholarly journals COVID-19 and headache: Impact on pre-existing and characteristics of de novo: A cross-sectional study

2021 ◽  
Vol 429 ◽  
pp. 119336
Author(s):  
Samar Farouk Ahmed ◽  
Fathi Abokalawa ◽  
Maram Alenzi ◽  
Raed Alroughani ◽  
Jasem Al Hashel
Keyword(s):  
De Novo ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Headache Impact

Hyperalgesia and Central Sensitization Signs in Patients with Cluster Headache: A Cross-Sectional Study

Pain Medicine ◽  
2019 ◽  
Vol 20 (12) ◽  
pp. 2562-2570 ◽  
Author(s):  
Alfonso Gil-Martínez ◽  
Gonzalo Navarro-Fernández ◽  
María Ángeles Mangas-Guijarro ◽  
Javier Díaz-de-Terán
Keyword(s):  
Negative Correlation ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Primary Headaches ◽  
Sectional Study ◽  
Cross Sectional ◽  
Sf 36 ◽  
Psychological Comorbidities ◽  
Moderate Negative Correlation ◽  
Headache Impact

Abstract Objective To investigate central sensitization (CS) in cluster headache (CH) and to evaluate its relationship with disease characteristics and psychological comorbidities. Design Cross-sectional study. Settings Whether CS occurs in CH, as it does in other primary headaches, is a subject of debate. Few studies have evaluated the presence of CS and its relationship with psychological comorbidities in patients with CH. Subjects Twenty patients with episodic or chronic CH and 16 healthy controls were recruited. Methods The variables evaluated included frequency, intensity and duration of headache attacks, pressure pain thresholds (PPTs) and wind-up (WU) ratios of pain bilaterally measured over trigeminal and extratrigeminal areas, and results of questionnaires regarding anxiety and depression (Hospital Anxiety and Depression Scale [HADS], Beck Depression Inventory [BDI], State-Trait Anxiety Inventory [STAI]), quality of life (Short Form-36 [SF-36]), headache impact (Headache Impact Test [HIT-6]), and allodynia (Allodynia Symptom Checklist [ASC]). Results PPT levels were significantly lower in the CH group compared with the healthy participants (all tested points, P < 0.001). No differences were found in WU ratios between groups. However, differences in HADS (P < 0.01), BDI (P < 0.01), STAI (P < 0.01), SF-36 (P < 0.01), HIT-6 (P < 0.001), and ASC (P < 0.01) were observed between groups. The healthy group showed a moderate negative correlation between SF-36 and BDI (rho = –0.59, P = 0.03). Likewise, the CH group showed a moderate negative correlation between frequency and BDI (rho = –0.52, P = 0.03), a strong positive correlation between duration and HADS (rho = 0.86, P < 0.01), and a moderate negative correlation between intensity and PPT over symptomatic V1 (rho = –0.66, P < 0.01) and over asymptomatic V1 (rho = –0.65, P < 0.01). The CH group also showed a moderate negative correlation between SF-36 and anxiety and depression variables. Conclusions Our findings show that patients with CH have lower PPT levels at cranial and extracranial points, suggesting, as in other primary headaches, the presence of CS. We have also found a high prevalence of psychiatric comorbidities that correlate with the length and frequency of attacks. These findings highlight the importance of a multidisciplinary approach to the treatment of patients with CH.

Patients’ participation in government-sponsored guidelines in Latin America: a cross-sectional study

2021 ◽  
pp. bmjebm-2020-111530
Author(s):  
Luis Ignacio Garegnani ◽  
Nicolás Meza ◽  
Pablo Rosón-Rodriguez ◽  
Camila Micaela Escobar-Liquitay ◽  
Marcelo Arancibia ◽  
...  
Keyword(s):  
Latin America ◽  
Latin American ◽  
De Novo ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Hand Search ◽  
Latin American Region ◽  
Government Websites ◽  
Grade Approach

BackgroundIt is recommended that patients actively participate in clinical practice guideline (CPG) development, which allows consideration of their values and preferences and improves adherence to recommendations. The development of CPGs throughout Latin America is variable and diverse, and the inclusion of patients’ participation is unknown.ObjectivesTo evaluate the methods of patients’ participation in government-sponsored CPGs in Latin America, the type of CPG development and the use of Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methods.DesignCross-sectional study. We included CPGs developed over the last 10 years through a comprehensive hand search in official national government websites and biomedical databases.Main outcome measureThe type of patients’ participation was coded according to five predefined categories. We also report the proportion of application of GRADE methods.ResultsWe included 408 CPGs from 10 countries: 74% (n=303) were de novo development, 13%(n=55) used an adaptation method and 10%(n=41) used both adaptation and de novo methods. Only 45% (n=185) applied the GRADE approach, ranging from 14% (n=12) of CPGs in Brazil to 89% (n=56) of CPGs in Colombia. Only 23% (n=95) of CPGs included at least one method of patients’ participation. Mexico was one of the largest CPG producers (100 CPGs), but none included methods of patients’ participation; in turn, in countries with lower production of government-sponsored CPGs, patients’ participation was found in almost 88%. Guidelines using the GRADE approach were more likely to use methods of patients’ participation. These methods were highly variable: 46% (n=44) incorporated patients in the panel, 81% (n=77) searched for evidence about patients’ values and preferences, 43% (n=39) used an external review of the draft recommendations by patients, 38% (n=36) used public comments, and 2% included other methods for stakeholders’ participation.ConclusionOnly one quarter of government-sponsored CPGs in the Latin American region incorporated a method for patients’ participation, which varied considerably across the selected countries. These findings highlight the need to improve CPG development methods to systematically incorporate patients’ values and preferences when drafting recommendations.

scholarly journals Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Jasem Youssef Al-Hashel ◽  
Fathi Abokalawa ◽  
Maram Alenzi ◽  
Raed Alroughani ◽  
Samar Farouk Ahmed
Keyword(s):  
De Novo ◽  
Primary Headache ◽  
Cross Sectional Study ◽  
Tension Type Headache ◽  
Sectional Study ◽  
Headache Disorders ◽  
Cross Sectional ◽  
Primary Headache Disorders ◽  
Male Patients ◽  
Type Headache

Abstract Background Coronavirus disease-19 is caused by the severe acute respiratory syndrome coronavirus 2 Headache is a common symptom during and after Coronavirus disease-19. We aimed to study headache character in relation to COVID-19. Methods This was a cross-sectional study. Patients who had Coronavirus disease-19, confirmed by reverse transcription polymerase chain reaction technique and presented to the headache clinic within 3 months after the onset of infections were identified to the study. Study included patients diagnosed as primary headache disorders according to The International Classification of Headache Disorders, 3rd edition. Participants were grouped into categories according to having previous or de novo headache. Descriptive data, paired sample t-test and the chi-squared test (X2) were used for statistical analyses of the data. Results A total of 121 patients were included in this study. Their mean age was 35.29 + 9.54 and most of them were females (83.5%). Prior to Coronavirus disease-19 infections, 78 (64.5%) had migraine and 11(9.1%) experienced a tension-type headache while 32 (26.4) reported de novo headache post Coronavirus disease-19. Patient had significant increase in headache days 11.09 ± 8.45 post Coronavirus disease-19 compared with 8.66 ± 7.49 headache days before Coronavirus disease-19 infection (p < 0.006). Post Coronavirus disease-19, the usage of analgesic increased significantly by the patient with migraine (2.31 ± 1.65 vs 3.05 ± 2.09, p = 0.002) while the patient with tension type headache had statistically significant increase in severity (5.556 ± 1.86 vs 7 ± 2.25, p = 0.033) and frequency (7 ± 6.29 vs 12.72 ± 7.96, p = 0.006) of headache attacks. Bi-frontal and temporal headache are the most reported (40.6% each) headache site among de novo headache group. Patients younger than 40 years had longer duration of the headache attack (18.50 ± 16.44 vs 5.5 ± 9.07, p = 0.045) post COVID-19. Male patients compared to females (8.66 ± 1.15 versus 5.93 ± 2.01 p = 0.04) had more severe headache post Coronavirus disease-19. De novo headache resolved within 1 month in most of patients (65.3%). Conclusion Primary headache get worse after Coronavirus disease-19. De novo primary headache is frequent post Coronavirus disease-19 and resolve within 1 month. Headaches related to Coronavirus disease-19 are severe, present as migraine phenotype. Young male patients with Coronavirus disease-19 tend to have worse headache.

Headache in chronic cocaine users: A cross-sectional study

Cephalalgia ◽  
2014 ◽  
Vol 34 (9) ◽  
pp. 671-678 ◽  
Author(s):  
Luisa Fofi ◽  
Valerio Orlandi ◽  
Nicola Vanacore ◽  
Maria C Mizzoni ◽  
Alba Rosa ◽  
...  
Keyword(s):  
Migraine Without Aura ◽  
De Novo ◽  
Cross Sectional Study ◽  
Consecutive Series ◽  
Sectional Study ◽  
Cross Sectional ◽  
Cocaine Use ◽  
Chronic Cocaine ◽  
Cocaine Users ◽  
Probable Migraine

Background Headache is one of the most common symptoms after cocaine use. Methods We investigated headache frequency and characteristics and the correlation between headache and acute cocaine intake in a cross-sectional study in a consecutive series of chronic cocaine users. Results Participation rate was 94.1%. Of the 80 subjects enrolled, 72 (90%) reported current headaches, in most cases migraine or probable migraine without aura. Of these 72, 29 (40.3%) had a headache history, whereas 43 (59.7%) reported de novo headache after beginning to use cocaine. After acute cocaine use, a large percentage of users reported headache attacks: 86.2% of previous headache sufferers (migraine or probable migraine without aura in all cases) and 93% of de novo headache sufferers (migraine/probable migraine without aura = 35; episodic tension-type headache = three patients; cocaine-induced headache= two patients). Most subjects reported that when they used cocaine headaches worsened. Conclusion Chronic cocaine use frequently seems to worsen or induce headache with migraine or migraine-like characteristics, probably owing to a serotoninergic and dopaminergic system impairment. In headache sufferers, especially those with migraine headaches, clinicians should enquire into possible cocaine use.

Does a Graduate Course in Fluency Disorders Make a Difference?

2010 ◽  
Vol 20 (1) ◽  
pp. 10-14 ◽  
Author(s):  
Evelyn R. Klein ◽  
Barbara J. Amster
Keyword(s):  
Undergraduate Students ◽  
Graduate Programs ◽  
The United States ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Graduate Course ◽  
Cross Sectional ◽  
Fluency Disorders ◽  
Introductory Course ◽  
Communicative Disorders

Abstract A study by Yaruss and Quesal (2002), based on responses from 134 of 239 ASHA accredited graduate programs, indicated that approximately 25% of graduate programs in the United States allow students to earn their degree without having coursework in fluency disorders and 66% of programs allow students to graduate without clinical experience treating people who stutter (PWS). It is not surprising that many clinicians report discomfort in treating PWS. This cross-sectional study compares differences in beliefs about the cause of stuttering between freshman undergraduate students enrolled in an introductory course in communicative disorders and graduate students enrolled and in the final weeks of a graduate course in fluency disorders.

Confidence toward vaccination as reported by parents of children admitted to a tertiary care hospital in Riyadh, Saudi Arabia: A cross sectional study

Vacunas ◽  
2020 ◽  
Vol 21 (2) ◽  
pp. 95-104 ◽  
Author(s):  
Y.M. AlGoraini ◽  
N.N. AlDujayn ◽  
M.A. AlRasheed ◽  
Y.E. Bashawri ◽  
S.S. Alsubaie ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Cross Sectional Study ◽  
Care Hospital ◽  
Sectional Study ◽  
Cross Sectional
Sign in / Sign up

Export Citation Format

Share Document